Trang kết quả 12 cho Khu vực: Chăm sóc sức khỏe Ngành: Công nghệ sinh học Thị trường chứng khoán - Báo giá & giá
Danh sách tất cả các chứng khoán và vốn chủ sở hữu kèm giá, vốn hoá thị trường, PE và EPS
Tất cả các quốc gia
- {{country.name}}
- Tất cả các quốc gia
- Hoa Kỳ (1012)
- Úc (58)
- Áo (16)
- Bỉ (7)
- Brazil (16)
- Canada (83)
- Trung Quốc (94)
- Đan Mạch (6)
- Phần Lan (4)
- Pháp (41)
- Đức (738)
- Hồng Kông (46)
- Ấn Độ (19)
- Ai-len (1)
- Israel (19)
- Ý (4)
- Nhật Bản (37)
- Mexico (28)
- Hà Lan (3)
- New Zealand (1)
- Na Uy (14)
- Ba Lan (9)
- Nga (2)
- Hàn Quốc (12)
- Tây Ban Nha (4)
- Thụy Điển (70)
- Thụy Sĩ (11)
- Đài Loan (67)
- Thái Lan (2)
- Thổ Nhĩ Kỳ (1)
- Vương quốc Anh (69)
Tất cả các sàn giao dịch
- {{item.name}}
- Tất cả các sàn giao dịch
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KOSDAQ (2)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (285)
- NasdaqGM (149)
- NasdaqGS (226)
- NSE (10)
- NYSE (10)
- NYSE American (19)
- NZSE (1)
- Oslo (14)
- OTC Markets EXMKT (112)
- OTC Markets OTCPK (125)
- OTC Markets OTCQB (38)
- OTC Markets OTCQX (8)
- Other OTC (39)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (39)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
Chăm sóc sức khỏe (2611)
- {{item.name}}
- Tất cả các khối
- Chăm sóc sức khỏe (2611)
Công nghệ sinh học (2611)
- {{item.name}}
- Tất cả các ngành
- Công nghệ sinh học (2611)
- Nhà sản xuất thuốc - Chung (279)
- Nhà sản xuất thuốc - Biệt dược & Thuốc gốc (1705)
- Gói y tế (57)
- Cơ sơ chăm sóc y tế (553)
- Nhà bán lẻ thuốc (155)
- Dịch vụ thông tin sức khỏe (419)
- Thiết bị y tế (913)
- Thiết bị & nguồn cung y tế (501)
- Chẩn đoán & nghiên cứu (427)
- Phân phối y tế (138)
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS |
|---|
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| TG Therapeutics, Inc. NKB2.F | $32.05 35.03 USD |
-4.07
|
$5.09B 5.56B USD | $45 49.19 USD | $32.05 35.03 USD | $32.05 35.03 USD | $5.09B 5.56B USD | 145.68 | $0.22 0.24 USD | |
| Abcam ABCM | $23.99 — |
0
|
$5.52B — | $0 — | $0 — | $0 — | $5.52B — | 0 | $0 — | |
| Legend Biotech Corporation 9LB.F | $27.2 29.73 USD |
+2.26
|
$5.02B 5.49B USD | $130 142.11 USD | $26.8 29.3 USD | $27.4 29.95 USD | $5.02B 5.49B USD | 0 | -$1.04 -1.1 USD | |
| Ionis Pharmaceuticals, Inc. ISI.F | $30.51 33.35 USD |
+0.49
|
$4.93B 5.39B USD | $755 825.32 USD | $30.51 33.35 USD | $30.51 33.35 USD | $4.93B 5.39B USD | 0 | -$2.63 -2.8 USD | |
| SK Biopharmaceuticals Co., Ltd. 326030.KS | $90,400 68.24 USD |
+0.78
|
$7.08T 5.34B USD | $153.53K 115.89 USD | $89,600 67.63 USD | $91,400 68.99 USD | $7.08T 5.34B USD | 0 | $0 0 USD | |
| Abcam plc A8C3.F | $11.7 12.79 USD |
0
|
$4.82B 5.27B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.82B 5.27B USD | 0 | $0 0 USD | |
| Axsome Therapeutics, Inc. 19X.F | $93.56 102.27 USD |
-2.2
|
$4.77B 5.21B USD | $17 18.58 USD | $93.56 102.27 USD | $93.56 102.27 USD | $4.77B 5.21B USD | 0 | -$5.05 -5.5 USD | |
| Abcam ABCZF | $22.25 — |
+0.68
|
$5.12B — | $4K — | $22.25 — | $22.25 — | $5.12B — | 2225.00 | $0.01 — | |
| Zealand Pharma A/S ZLDPF | $71.11 — |
-0.13
|
$5.03B — | $321 — | $69.57 — | $71.11 — | $5.03B — | 0 | -$2.64 — | |
| Biocon Limited BIOCON.BO | $329.3 3.98 USD |
-0.41
|
$401.2B 4.85B USD | $29.02K 351.13 USD | $327.75 3.97 USD | $332.6 4.02 USD | $401.2B 4.85B USD | 38.92 | $8.46 0.1 USD | |
| Alpine Immune Sciences, Inc. 34LA.F | $59 64.49 USD |
0
|
$4.1B 4.48B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.1B 4.48B USD | 0 | $0 0 USD | |
| Alpine Immune Sciences ALPN | $64.97 — |
0
|
$4.46B — | $0 — | $0 — | $0 — | $4.46B — | 0 | $0 — | |
| Sarepta Therapeutics, Inc. S1RP34.SA | $10.97 2.22 USD |
+0.27
|
$21.92B 4.44B USD | $0 0 USD | $0 0 USD | $0 0 USD | $21.92B 4.44B USD | 0 | -$0.74 -0.1 USD | |
| ALK-Abelló A/S 0OIR.IL | $149.45 21.91 USD |
0
|
$30B 4.4B USD | $13.2K 1.94K USD | $0 0 USD | $0 0 USD | $30B 4.4B USD | 92.82 | $1.61 0.24 USD | |
| Vaxcyte, Inc. 5VA.MU | $29.8 32.58 USD |
-1.32
|
$3.84B 4.2B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.84B 4.2B USD | 0 | -$3.51 -3.8 USD | |
| Agios Pharmaceuticals, Inc. AGIO.MX | $1,222 72.36 USD |
0
|
$70.77B 4.19B USD | $0 0 USD | $1,222 72.36 USD | $1,222 72.36 USD | $70.77B 4.19B USD | 5.16 | $236.58 14.01 USD | |
| Asymchem Laboratories (Tianjin) Co., Ltd. 7K90.F | $7.75 8.47 USD |
-5.49
|
$3.8B 4.15B USD | $170 185.83 USD | $7.75 8.47 USD | $7.75 8.47 USD | $3.8B 4.15B USD | 22.79 | $0.34 0.37 USD | |
| Mirati Therapeutics, Inc. 26M.F | $53.3 58.26 USD |
0
|
$3.79B 4.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.79B 4.14B USD | 0 | $0 0 USD | |
| Akero Therapeutics, Inc. 0K4.F | $46.18 50.48 USD |
+1.94
|
$3.78B 4.14B USD | $260 284.22 USD | $46.23 50.54 USD | $46.23 50.54 USD | $3.78B 4.14B USD | 0 | -$3.29 -3.5 USD | |
| Mirati Therapeutics MRTX | $58.7 — |
0
|
$4.12B — | $0 — | $0 — | $0 — | $4.12B — | 0 | $0 — | |
| Vaxcyte, Inc. 5VA.F | $28.2 30.83 USD |
-2.76
|
$3.73B 4.08B USD | $160 174.9 USD | $28.2 30.83 USD | $28.2 30.83 USD | $3.73B 4.08B USD | 0 | -$3.51 -3.8 USD | |
| Zealand Pharma A/S 0NZU.IL | $464 68.03 USD |
0
|
$27.67B 4.06B USD | $8K 1.17K USD | $0 0 USD | $0 0 USD | $27.67B 4.06B USD | 0 | -$15.13 -2.2 USD | |
| Merus N.V. 2GH.F | $48.8 53.34 USD |
-2.01
|
$3.67B 4.02B USD | $200 218.63 USD | $48.8 53.34 USD | $49.2 53.78 USD | $3.67B 4.02B USD | 0 | -$3.66 -4.0008 USD | |
| BB Biotech AG BB.MI | $65.2 71.27 USD |
0
|
$3.58B 3.91B USD | $10.08K 11.02K USD | $51.6 56.41 USD | $52.9 57.83 USD | $3.58B 3.91B USD | 5.75 | $11.32 12.37 USD | |
| Rhythm Pharmaceuticals, Inc. 1RV.F | $56 61.22 USD |
-2.61
|
$3.56B 3.89B USD | $20 21.86 USD | $56 61.22 USD | $56 61.22 USD | $3.56B 3.89B USD | 0 | -$2.46 -2.6 USD | |
| Zai Lab Limited 1ZL.F | $31.2 34.11 USD |
+5.41
|
$3.51B 3.83B USD | $230 251.42 USD | $31.2 34.11 USD | $31.2 34.11 USD | $3.51B 3.83B USD | 0 | -$2.2 -2.4 USD | |
| CymaBay Therapeutics, Inc. C0I.F | $29.8 32.58 USD |
0
|
$3.43B 3.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.43B 3.75B USD | 0 | $0 0 USD | |
| Camurus AB (publ) 7CA.F | $58.2 63.62 USD |
-5.06
|
$3.41B 3.73B USD | $1.22K 1.34K USD | $58.2 63.62 USD | $58.2 63.62 USD | $3.41B 3.73B USD | 69.28 | $0.84 0.92 USD | |
| CymaBay Therapeutics CBAY | $32.48 — |
0
|
$3.73B — | $0 — | $0 — | $0 — | $3.73B — | 0 | $0 — | |
| Genscript Biotech GNNSF | $1.7 — |
+1.8
|
$3.7B — | $1K — | $1.7 — | $1.7 — | $3.7B — | 0 | -$0.08 — | |
| Sarepta Therapeutics, Inc. AB3A.F | $34.34 37.54 USD |
+1.15
|
$3.37B 3.69B USD | $50 54.66 USD | $34.34 37.54 USD | $34.34 37.54 USD | $3.37B 3.69B USD | 0 | -$2.31 -2.5 USD | |
| Krystal Biotech, Inc. 4KB.SG | $114.9 125.6 USD |
+0.61
|
$3.37B 3.69B USD | $0 0 USD | $114.6 125.27 USD | $114.9 125.6 USD | $3.37B 3.69B USD | 31.30 | $3.67 4.01 USD | |
| Krystal Biotech, Inc. 4KB.F | $114.65 125.33 USD |
+0.44
|
$3.37B 3.68B USD | $190 207.7 USD | $114.65 125.33 USD | $114.65 125.33 USD | $3.37B 3.68B USD | 31.32 | $3.66 4 USD | |
| Cytokinetics, Incorporated KK3A.F | $27.6 30.17 USD |
-1.43
|
$3.35B 3.66B USD | $150 163.97 USD | $27.6 30.17 USD | $28.2 30.83 USD | $3.35B 3.66B USD | 0 | -$4.65 -5.08 USD | |
| Genscript Biotech Corporation G51.F | $1.48 1.62 USD |
-1.66
|
$3.22B 3.52B USD | $2.77K 3.03K USD | $1.45 1.58 USD | $1.48 1.62 USD | $3.22B 3.52B USD | 0 | -$0.07 -0.07 USD | |
| ACADIA Pharmaceuticals Inc. DR6.F | $18.93 20.69 USD |
-3
|
$3.17B 3.46B USD | $100 109.31 USD | $18.93 20.69 USD | $18.93 20.69 USD | $3.17B 3.46B USD | 15.77 | $1.2 1.31 USD | |
| Ultragenyx Pharmaceutical Inc. UP0.F | $31.8 34.76 USD |
0
|
$3.05B 3.34B USD | $54 59.03 USD | $31.8 34.76 USD | $31.8 34.76 USD | $3.05B 3.34B USD | 0 | -$5.1 -5.5 USD | |
| Galapagos NV GXE.DE | $44.47 48.61 USD |
0
|
$2.93B 3.2B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.93B 3.2B USD | 0 | $0 0 USD | |
| Laboratorios Farmaceuticos Rovi, S.A. 41L.F | $55.35 60.51 USD |
+2.41
|
$2.91B 3.18B USD | $19 20.77 USD | $55.35 60.51 USD | $55.35 60.51 USD | $2.91B 3.18B USD | 20.27 | $2.73 2.98 USD | |
| Syngene International Limited SYNGENE.BO | $643.25 7.78 USD |
-0.59
|
$258.44B 3.13B USD | $3.01K 36.45 USD | $642.8 7.78 USD | $648 7.84 USD | $258.44B 3.13B USD | 52.04 | $12.36 0.15 USD | |
| VitaSpring Biomedical VSBC | $1 — |
0
|
$3.1B — | $100 — | $1 — | $1 — | $3.1B — | 0 | $0 — | |
| Viking Therapeutics, Inc. 1VT.F | $23.98 26.21 USD |
+3.23
|
$2.75B 3.01B USD | $296 323.57 USD | $23.02 25.16 USD | $23.98 26.21 USD | $2.75B 3.01B USD | 0 | -$1.02 -1.1 USD | |
| Catalyst Pharmaceuticals, Inc. CN2.F | $22.16 24.22 USD |
+2.69
|
$2.71B 2.96B USD | $500 546.57 USD | $22.16 24.22 USD | $22.16 24.22 USD | $2.71B 2.96B USD | 16.17 | $1.37 1.5 USD | |
| Crinetics Pharmaceuticals, Inc. 6Z4.F | $28 30.61 USD |
-0.71
|
$2.63B 2.87B USD | $60 65.59 USD | $28 30.61 USD | $28 30.61 USD | $2.63B 2.87B USD | 0 | -$3.33 -3.6 USD | |
| Morphic Holding MORF | $56.99 — |
0
|
$2.86B — | $0 — | $0 — | $0 — | $2.86B — | 0 | $0 — | |
| MorphoSys AG MOR | $18.96 — |
0
|
$2.86B — | $0 — | $0 — | $0 — | $2.86B — | 0 | $0 — | |
| MorphoSys AG MOR2.F | $16.8 18.36 USD |
0
|
$2.61B 2.85B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.61B 2.85B USD | 0 | $0 0 USD | |
| Morphic Holding, Inc. 31Y.F | $50 54.66 USD |
0
|
$2.6B 2.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.6B 2.84B USD | 0 | $0 0 USD | |
| MorphoSys AG MOR.VI | $68.15 74.5 USD |
0
|
$2.57B 2.81B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.57B 2.81B USD | 0 | $0 0 USD | |
| MorphoSys AG MOR.F | $67.8 74.11 USD |
0
|
$2.55B 2.79B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.55B 2.79B USD | 0 | $0 0 USD | |
| MorphoSys AG MOR.DE | $67.25 73.51 USD |
0
|
$2.53B 2.77B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.53B 2.77B USD | 0 | $0 0 USD | |
| Scholar Rock Holding Corporation 2QK.F | $26.6 29.08 USD |
-1.48
|
$2.53B 2.77B USD | $20 21.86 USD | $26.6 29.08 USD | $26.6 29.08 USD | $2.53B 2.77B USD | 0 | -$2.24 -2.4 USD | |
| MorphoSys AG MPSYF | $73.27 — |
0
|
$2.76B — | $0 — | $0 — | $0 — | $2.76B — | 0 | $0 — | |
| ABL Bio Inc. 298380.KQ | $75,800 57.22 USD |
-0.79
|
$3.64T 2.75B USD | $826.98K 624.24 USD | $75,100 56.69 USD | $78,900 59.56 USD | $3.64T 2.75B USD | 0 | $0 0 USD | |
| SK bioscience Co.,Ltd. 302440.KS | $46,150 34.84 USD |
0
|
$3.55T 2.68B USD | $127.84K 96.5 USD | $45,550 34.38 USD | $46,950 35.44 USD | $3.55T 2.68B USD | 0 | $0 0 USD | |
| MorphoSys AG 0NDV.IL | $67.6 73.9 USD |
0
|
$2.34B 2.56B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.34B 2.56B USD | 0 | $0 0 USD | |
| Bavarian Nordic A/S 0DPB.IL | $182.2 26.71 USD |
0
|
$17.1B 2.51B USD | $437 64.07 USD | $0 0 USD | $0 0 USD | $17.1B 2.51B USD | 12.93 | $14.09 2.07 USD | |
| ImmunityBio, Inc. 26CA.F | $2.52 2.76 USD |
-0.9
|
$2.25B 2.46B USD | $4K 4.37K USD | $2.46 2.69 USD | $2.59 2.83 USD | $2.25B 2.46B USD | 0 | -$0.5 -0.5 USD | |
| Ascentage Pharma Group International 36X.F | $6.05 6.61 USD |
-0.82
|
$2.14B 2.34B USD | $200 218.63 USD | $6.05 6.61 USD | $6.05 6.61 USD | $2.14B 2.34B USD | 0 | -$0.16 -0.1 USD | |
| Xenon Pharmaceuticals Inc. XP0.F | $26.6 29.08 USD |
-0.75
|
$2.06B 2.25B USD | $40 43.73 USD | $26.6 29.08 USD | $26.6 29.08 USD | $2.06B 2.25B USD | 0 | -$2.82 -3.08 USD | |
| Arrowhead Pharmaceuticals, Inc. HDP1.F | $14.56 15.91 USD |
+0.41
|
$2.01B 2.2B USD | $80 87.45 USD | $14.56 15.91 USD | $14.56 15.91 USD | $2.01B 2.2B USD | 0 | -$1.09 -1.1 USD | |
| Bavarian Nordic A/S BV3.DE | $25.3 27.66 USD |
0
|
$1.99B 2.18B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.99B 2.18B USD | 0 | $0 0 USD | |
| Vericel Corporation ATQP.F | $37.6 41.1 USD |
+3.87
|
$1.98B 2.17B USD | $130 142.11 USD | $37.6 41.1 USD | $37.6 41.1 USD | $1.98B 2.17B USD | 751.99 | $0.05 0.05 USD | |
| BioCryst Pharmaceuticals, Inc. BO1.F | $9.47 10.35 USD |
-4.19
|
$1.98B 2.17B USD | $190 207.7 USD | $9.47 10.35 USD | $9.58 10.47 USD | $1.98B 2.17B USD | 0 | -$0.23 -0.2 USD | |
| Galapagos NV G1LP34.SA | $8.07 1.64 USD |
0
|
$10.65B 2.16B USD | $0 0 USD | $0 0 USD | $0 0 USD | $10.65B 2.16B USD | 0 | -$0.88 -0.1 USD | |
| Bavarian Nordic A/S BVNKF | $27.5 — |
+4.96
|
$2.14B — | $668 — | $27.3 — | $27.5 — | $2.14B — | 10.65 | $2.58 — | |
| Apellis Pharmaceuticals, Inc. 1JK.F | $15.55 17 USD |
-8.45
|
$1.95B 2.14B USD | $240 262.35 USD | $15.55 17 USD | $15.55 17 USD | $1.95B 2.14B USD | 0 | -$1.58 -1.7 USD | |
| Veracyte, Inc. 12V.F | $24 26.24 USD |
+3.45
|
$1.94B 2.12B USD | $50 54.66 USD | $23.6 25.8 USD | $24 26.24 USD | $1.94B 2.12B USD | 64.86 | $0.37 0.4 USD | |
| Mirum Pharmaceuticals, Inc. 08D.F | $37.4 40.88 USD |
-2.09
|
$1.9B 2.08B USD | $26 28.42 USD | $37.4 40.88 USD | $37.8 41.32 USD | $1.9B 2.08B USD | 0 | -$1.41 -1.5 USD | |
| Denali Therapeutics Inc. 4DN.F | $12.55 13.72 USD |
+3.08
|
$1.9B 2.07B USD | $200 218.63 USD | $12.55 13.72 USD | $12.55 13.72 USD | $1.9B 2.07B USD | 0 | -$2.35 -2.5 USD | |
| Denali Therapeutics Inc. 4DN.MU | $12.51 13.68 USD |
+3.05
|
$1.9B 2.07B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.9B 2.07B USD | 0 | -$2.35 -2.5 USD | |
| SanBio Company SNBIF | $11.32 — |
+143.44
|
$2.06B — | $993 — | $11.32 — | $11.32 — | $2.06B — | 0 | -$0.29 — | |
| Bavarian Nordic A/S BV3.F | $23.8 26.02 USD |
-0.21
|
$1.88B 2.05B USD | $8 8.75 USD | $23.8 26.02 USD | $24.47 26.75 USD | $1.88B 2.05B USD | 10.57 | $2.25 2.46 USD | |
| BioArctic AB (publ) 0RV2.IL | $200 19.52 USD |
-0.3
|
$20.01B 1.95B USD | $8.17K 797.01 USD | $0 0 USD | $0 0 USD | $20.01B 1.95B USD | 65.14 | $3.07 0.3 USD | |
| Ligand Pharmaceuticals Incorporated LGDN.F | $90.5 98.93 USD |
+1.12
|
$1.76B 1.92B USD | $20 21.86 USD | $90.5 98.93 USD | $90.5 98.93 USD | $1.76B 1.92B USD | 0 | -$6.38 -6.9 USD | |
| Galapagos GLPGF | $27.5 — |
+22.82
|
$1.92B — | $200 — | $27.5 — | $27.5 — | $1.92B — | 0 | -$3.11 — | |
| Agios Pharmaceuticals, Inc. 8AP.F | $29.4 32.14 USD |
+1.38
|
$1.76B 1.92B USD | $54 59.03 USD | $29.4 32.14 USD | $29.4 32.14 USD | $1.76B 1.92B USD | 2.89 | $10.14 11.08 USD | |
| Everest Medicines Limited 6HN.F | $5.1 5.57 USD |
-0.97
|
$1.72B 1.88B USD | $212 231.74 USD | $5.1 5.57 USD | $5.1 5.57 USD | $1.72B 1.88B USD | 0 | -$0.4 -0.4 USD | |
| Mesoblast MEOBF | $1.44 — |
+1.18
|
$1.83B — | $170 — | $1.44 — | $1.44 — | $1.83B — | 0 | -$0.09 — | |
| Fusion Pharmaceuticals FUSN | $21.41 — |
0
|
$1.82B — | $0 — | $0 — | $0 — | $1.82B — | 0 | $0 — | |
| Galapagos NV GXEA.F | $24.8 27.11 USD |
-0.8
|
$1.66B 1.82B USD | $4 4.37 USD | $24.8 27.11 USD | $24.8 27.11 USD | $1.66B 1.82B USD | 0 | -$2.73 -2.9 USD | |
| BioArctic AB (publ) B9A.F | $18.18 19.87 USD |
+2.36
|
$1.66B 1.81B USD | $500 546.57 USD | $18.07 19.75 USD | $18.18 19.87 USD | $1.66B 1.81B USD | 19.54 | $0.93 1.02 USD | |
| Pharma Mar, S.A. 0RC6.IL | $91.48 99.99 USD |
+0.91
|
$1.65B 1.81B USD | $1.14K 1.25K USD | $0 0 USD | $0 0 USD | $1.65B 1.81B USD | 82.40 | $1.11 1.21 USD | |
| Galapagos NV GXE.F | $24.46 26.74 USD |
-1.69
|
$1.65B 1.8B USD | $150 163.97 USD | $24.46 26.74 USD | $24.84 27.15 USD | $1.65B 1.8B USD | 0 | -$2.73 -2.9 USD | |
| Immunocore Holdings plc 6YG.F | $32.8 35.85 USD |
-1.8
|
$1.65B 1.8B USD | $149 162.88 USD | $32.4 35.42 USD | $33 36.07 USD | $1.65B 1.8B USD | 0 | -$0.38 -0.4 USD | |
| Immunocore Holdings plc 6YG.MU | $32.8 35.85 USD |
-2.38
|
$1.64B 1.79B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.64B 1.79B USD | 0 | -$1.32 -1.4 USD | |
| Pharma Mar PHMMF | $103.6 — |
+10.66
|
$1.79B — | $6.07K — | $103.6 — | $103.6 — | $1.79B — | 80.94 | $1.28 — | |
| Galapagos NV GLPG.VI | $24.7 27 USD |
-2.6
|
$1.63B 1.79B USD | $0 0 USD | $24.7 27 USD | $25.26 27.61 USD | $1.63B 1.79B USD | 0 | -$2.73 -2.9 USD | |
| Amicus Therapeutics, Inc. AM6.F | $5.3 5.79 USD |
-2.75
|
$1.63B 1.78B USD | $47 51.38 USD | $5.3 5.79 USD | $5.3 5.79 USD | $1.63B 1.78B USD | 0 | -$0.08 -0.08 USD | |
| Ambrx Biopharma AMAM | $28 — |
0
|
$1.77B — | $0 — | $0 — | $0 — | $1.77B — | 0 | $0 — | |
| Genus GENSF | $26.6 — |
-4.55
|
$1.77B — | $5.42K — | $26.6 — | $26.6 — | $1.77B — | 0 | -$0.09 — | |
| IDEAYA Biosciences, Inc. 30J.F | $18.4 20.11 USD |
-3.16
|
$1.61B 1.76B USD | $115 125.71 USD | $18.4 20.11 USD | $18.4 20.11 USD | $1.61B 1.76B USD | 0 | -$3.21 -3.5 USD | |
| PeptiDream PPTDF | $13.53 — |
+3.24
|
$1.75B — | $2.27K — | $13.53 — | $13.53 — | $1.75B — | 17.12 | $0.79 — | |
| IDEAYA Biosciences, Inc. 30J.SG | $18 19.68 USD |
-2.7
|
$1.58B 1.73B USD | $0 0 USD | $18 19.68 USD | $18 19.68 USD | $1.58B 1.73B USD | 0 | -$3.21 -3.5 USD | |
| Pharma Mar, S.A. PMRA.F | $90.4 98.82 USD |
-1.09
|
$1.56B 1.71B USD | $410 448.19 USD | $90.4 98.82 USD | $90.4 98.82 USD | $1.56B 1.71B USD | 80.00 | $1.13 1.24 USD | |
| Genus plc GBE.F | $23.4 25.58 USD |
+0.86
|
$1.55B 1.7B USD | $610 666.81 USD | $23.4 25.58 USD | $23.4 25.58 USD | $1.55B 1.7B USD | 0 | -$0.07 -0.07 USD | |
| BB Biotech AG BIOEE.SW | $25.35 28.84 USD |
0
|
$1.45B 1.65B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.45B 1.65B USD | 0 | $0 0 USD | |
| Biotest Aktiengesellschaft BIO.F | $42.2 46.13 USD |
+0.48
|
$1.45B 1.58B USD | $30 32.79 USD | $42.2 46.13 USD | $42.2 46.13 USD | $1.45B 1.58B USD | 0 | -$0.63 -0.6 USD | |
| Biotest Aktiengesellschaft BIO3.F | $29.8 32.58 USD |
0
|
$1.44B 1.57B USD | $500 546.57 USD | $29.8 32.58 USD | $29.8 32.58 USD | $1.44B 1.57B USD | 0 | -$0.63 -0.6 USD | |
| Biotest Aktiengesellschaft BIO.DE | $42.6 46.57 USD |
-0.47
|
$1.43B 1.57B USD | $11 12.02 USD | $42.2 46.13 USD | $43 47 USD | $1.43B 1.57B USD | 0 | -$0.63 -0.6 USD | |
|
Không có cổ phiếu ưa thích
Bạn chưa có cổ phiếu ưa thích nào, hãy thêm nó vào mục ưa thích để thấy nó tại đây |
||||||||||